De Novo Protein Switches for Conformational Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current technologies have not successfully designed proteins that can switch conformations in response to external inputs, as achieving multiple stable states with small free energy differences is challenging.

Innovation Solution

The development of non-naturally occurring polypeptides comprising a helical bundle with alpha-helices connected by amino acid linkers, which can undergo conformational switching upon binding with a key polypeptide, thereby activating bioactive peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If proteins are designed to fold into lowest free energy state, then structural stability is improved, but conformational switching capability deteriorates

Engineering Contradiction:
Improvestructural stabilityVSAvoidconformational switching capability
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent designs proteins with dynamic conformational switching capability by creating multiple stable states (folded and unfolded) that can be interconverted. The helical bundle structure with carefully designed linkers allows the protein to transition between conformations in response to external inputs, making the system dynamic rather than static.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent controls the free energy landscape by adjusting design parameters such as helix length (18-60 amino acids), linker length (2-10 amino acids), and number of helices (2-7). These parameter changes enable tuning of the energy difference between folded and unfolded states, allowing conformational switching while maintaining sufficient stability.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If free energy gap between folded structure and other structures is maximized, then folding stability is improved, but conformational switching capability deteriorates

Engineering Contradiction:
Improvefolding stabilityVSAvoidconformational switching capability
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent optimizes the free energy gap by adjusting structural parameters: helix length (18-60 residues), linker length (2-10 residues), and helix count (2-7). These parameter changes create a controlled energy landscape where the folded state is stable but not so stable that switching becomes impossible, achieving a balance between folding stability and switching capability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The design creates a dynamic system with multiple accessible states by controlling the energy landscape. The helical bundle with flexible linkers allows the protein to populate both folded and unfolded states, enabling conformational switching while maintaining adequate folding stability through optimized structural parameters.

Inventive Principle:
Principle #15Dynamics

3Adaptability or versatility

If free energy differences between states are made small, then conformational switching capability is improved, but structural stability deteriorates

Engineering Contradiction:
Improveconformational switching capabilityVSAvoidstructural stability
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent achieves the right balance by optimizing structural parameters: helix length (18-60 amino acids provides stability), linker length (2-10 amino acids provides flexibility), and number of helices (2-7). These parameter changes create small enough free energy differences for switching while maintaining sufficient structural stability through the helical bundle architecture.

Inventive Principle:
Principle #35Parameter changes

4Adaptability or versatility

If de novo design of conformational switching proteins is attempted, then conformational switching capability is improved, but design reliability deteriorates

Engineering Contradiction:
Improveconformational switching capabilityVSAvoiddesign reliability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent segments the protein into distinct functional modules: stable helical bundles (2-7 helices with 18-60 residues each) and flexible linkers (2-10 residues). This segmentation allows independent optimization of stability (helices) and switching capability (linkers), improving design reliability while achieving conformational switching.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent establishes reliable design parameters through systematic optimization: helix length (18-60 residues), linker length (2-10 residues), and helix count (2-7). These parameter ranges have been validated to produce functional conformational switches, improving design reliability by providing proven design rules rather than trial-and-error approaches.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the creation of protein switches that can effectively toggle the activity of bioactive peptides, offering a modular and tunable mechanism for controlling biological functions.

Implementation Method 1

proteins that can switch conformations is more challenging

Methodology Applied
Scientific EffectConformational change:

Implementation Method 2

proteins fold into their lowest free energy state

Methodology Applied
Scientific EffectProtein folding:

Implementation Method 3

amino acid linkers connecting each alpha helix

Methodology Applied
Scientific EffectPeptide bonding: Chemical Bonding

Implementation Method 4

bioactive peptides are capable of selectively binding to a defined target

Methodology Applied
Scientific EffectSelective binding:

Data Source

PatentUS20250188125A1De novo Design of Protein Switches
Publication Date: 2025.06.12 UNIV OF WASHINGTON
  • US20250188125A1 patent drawing
  • US20250188125A1 patent drawing
  • US20250188125A1 patent drawing

AI summary

Disclosed are protein switches that can sequester bioactive peptides and/or binding domains, holding them in an inactive (“off”) state, until combined with a second designed polypeptide called the key, which induces a conformational change that activates (“on”) the bioactive peptide or binding domain, components of such protein switches, and their use.